Who Paid My Doc
a randomised,open label,phase III study of saruparib AZD5305 plus camizestrant compared with physicians choice CDK4 6 inhibitor plus endocrine therapy or plus camizestrant for the first line treatment of patients with BRCA1,BRCA2,or PALB2 mutations and hormone receptor positive, HER2 negative IHC 0,1+,2+ISH non-amplified advanced breast cancer evoPAR breast01
Research payments
$1,346,386
Through program year 2025, $1,346,386 in research payments was reported against a randomised,open label,phase III study of saruparib AZD5305 plus camizestrant compared with physicians choice CDK4 6 inhibitor plus endocrine therapy or plus camizestrant for the first line treatment of patients with BRCA1,BRCA2,or PALB2 mutations and hormone receptor positive, HER2 negative IHC 0,1+,2+ISH non-amplified advanced breast cancer evoPAR breast01, across 35 payments.
- Paid by (largest first)
- AstraZeneca Pharmaceuticals LP; AstraZeneca UK Limited
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $1,243,535 | 31 |
| 2024 | Research | $102,851 | 4 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Danish Safi Morgantown, WV Named on 2 payments
- Filipa Lynce Boston, MA Named on 2 payments
- Marie Wood Littleton, CO Named on 2 payments
- Faisal Musa Dearborn, MI Named on 2 payments
- Amol Rao Fountain Valley, CA Named on 1 payment
- Mihran Shirinian Glendale, CA Named on 1 payment
- Manas Agastya Tacoma, WA Named on 1 payment
- Sara Nunnery Mount Juliet, TN Named on 1 payment
- Nancy Chandler New York, NY Named on 1 payment
- James D Olimpio New Hyde Park, NY Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.